UK markets open in 37 minutes

Kyverna Therapeutics, Inc. (KYTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.50+0.14 (+1.90%)
At close: 04:00PM EDT
7.50 0.00 (0.00%)
After hours: 07:33PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Cash flows from operating activities
Net income
-75,916
-60,366
-28,893
-26,350
Depreciation & amortisation
1,795
1,707
1,051
586
Stock-based compensation
4,030
2,220
929
7,250
Change in working capital
3,069
3,424
-10,327
-4,491
Accounts payable
7,046
4,083
677
11
Other working capital
-67,613
-53,031
-36,881
-23,444
Other non-cash items
1,862
1,720
1,411
829
Net cash provided by operating activities
-66,477
-52,410
-36,113
-22,155
Cash flows from investing activities
Investments in property, plant and equipment
-1,136
-621
-768
-1,289
Purchases of investments
-200,183
-54,847
-56,495
0
Sales/maturities of investments
56,000
46,683
43,166
0
Net cash used for investing activities
-145,319
-8,785
-14,097
-1,289
Cash flows from financing activities
Debt repayment
-844
-781
-249
-41
Other financing activities
-
-1,646
-
-
Net cash used provided by (used for) financing activities
396,311
58,118
11,880
72,523
Net change in cash
184,515
-3,077
-38,330
49,079
Cash at beginning of period
40,342
38,289
76,619
27,540
Cash at end of period
224,857
35,212
38,289
76,619
Free cash flow
Operating cash flow
-66,477
-52,410
-36,113
-22,155
Capital expenditure
-1,136
-621
-768
-1,289
Free cash flow
-67,613
-53,031
-36,881
-23,444